메뉴 건너뛰기




Volumn 88, Issue 9, 2014, Pages 4897-4907

VSV-GP: A potent viral vaccine vector that boosts the immune response upon repeated applications

Author keywords

[No Author keywords available]

Indexed keywords

OVALBUMIN; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS PSEUDOTYPED WITH THE GLYCOPROTEIN VIRUS VECTOR; VIRUS VACCINE; VIRUS VECTOR;

EID: 84897479022     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03276-13     Document Type: Article
Times cited : (52)

References (55)
  • 1
    • 37549026844 scopus 로고    scopus 로고
    • Replicating and non-replicating viral vectors for vaccine development
    • Robert-Guroff M. 2007. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol. 18:546-556. http://dx.doi.org/10.1016/j.copbio.2007.10.010.
    • (2007) Curr. Opin. Biotechnol. , vol.18 , pp. 546-556
    • Robert-Guroff, M.1
  • 2
    • 84880353735 scopus 로고    scopus 로고
    • Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus
    • Manrique J, Piatak M, Lauer W, Johnson W, Mansfield K, Lifson J, Desrosiers R. 2013. Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus. J. Virol. 87:7246-7254. http://dx.doi.org/10.1128/JVI.00798-13.
    • (2013) J. Virol. , vol.87 , pp. 7246-7254
    • Manrique, J.1    Piatak, M.2    Lauer, W.3    Johnson, W.4    Mansfield, K.5    Lifson, J.6    Desrosiers, R.7
  • 6
  • 7
    • 0036184412 scopus 로고    scopus 로고
    • High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses
    • Haglund K, Leiner I, Kerksiek K, Buonocore L, Pamer E, Rose JK. 2002. High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. J. Virol. 76:2730-2738. http://dx.doi.org/10.1128/JVI.76.6.2730-2738.2002.
    • (2002) J. Virol. , vol.76 , pp. 2730-2738
    • Haglund, K.1    Leiner, I.2    Kerksiek, K.3    Buonocore, L.4    Pamer, E.5    Rose, J.K.6
  • 8
    • 80054741833 scopus 로고    scopus 로고
    • Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections
    • Geisbert TW, Feldmann H. 2011. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 204(Suppl 3):S1075-S1081. http://dx.doi.org/10.1093/infdis/jir349.
    • (2011) J. Infect. Dis. , vol.204 , Issue.SUPPL. 3
    • Geisbert, T.W.1    Feldmann, H.2
  • 10
    • 77950826934 scopus 로고    scopus 로고
    • Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge
    • Schwartz JA, Buonocore L, Suguitan AL, Jr, Silaghi A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK. 2010. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J. Virol. 84:4611-4618. http://dx.doi.org/10.1128/JVI.02637-09.
    • (2010) J. Virol. , vol.84 , pp. 4611-4618
    • Schwartz, J.A.1    Buonocore, L.2    Suguitan Jr., A.L.3    Silaghi, A.4    Kobasa, D.5    Kobinger, G.6    Feldmann, H.7    Subbarao, K.8    Rose, J.K.9
  • 11
    • 0001424129 scopus 로고    scopus 로고
    • Rhabdoviridae: the viruses and their replication
    • Fields BN, Knipe DM, Howley PM (ed), Philadelphia, PA.
    • Wagner RR, Rose JK. 1996. Rhabdoviridae: the viruses and their replication, p 1121-1136. In Fields BN, Knipe DM, Howley PM (ed), Fields virology. Lippincott-Raven, Philadelphia, PA.
    • (1996) Fields virology. Lippincott-Raven , pp. 1121-1136
    • Wagner, R.R.1    Rose, J.K.2
  • 12
    • 0034527958 scopus 로고    scopus 로고
    • VSV-NJ on Ossabaw Island, Georgia. The truth is out there
    • Stallknecht DE. 2000. VSV-NJ on Ossabaw Island, Georgia. The truth is out there. Ann. N. Y. Acad. Sci. 916:431-436. http://dx.doi.org/10.1111/j.1749-6632.2000.tb05322.x.
    • (2000) Ann. N. Y. Acad. Sci. , vol.916 , pp. 431-436
    • Stallknecht, D.E.1
  • 13
    • 2342531185 scopus 로고    scopus 로고
    • Vesicular stomatitis virus: re-inventing the bullet
    • Lichty BD, Power AT, Stojdl DF, Bell JC. 2004. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol. Med. 10:210-216. http://dx.doi.org/10.1016/j.molmed.2004.03.003.
    • (2004) Trends Mol. Med. , vol.10 , pp. 210-216
    • Lichty, B.D.1    Power, A.T.2    Stojdl, D.F.3    Bell, J.C.4
  • 14
    • 0034090316 scopus 로고    scopus 로고
    • Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope
    • Haglund K, Forman J, Krausslich HG, Rose JK. 2000. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268: 112-121. http://dx.doi.org/10.1006/viro.1999.0120.
    • (2000) Virology , vol.268 , pp. 112-121
    • Haglund, K.1    Forman, J.2    Krausslich, H.G.3    Rose, J.K.4
  • 15
    • 84865139750 scopus 로고    scopus 로고
    • Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
    • Muik A, Dold C, Geiss Y, Volk A, Werbizki M, Dietrich U, von Laer D. 2012. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy. J. Mol. Med. 90:959-970. http://dx.doi.org/10.1007/s00109-012-0863-6.
    • (2012) J. Mol. Med. , vol.90 , pp. 959-970
    • Muik, A.1    Dold, C.2    Geiss, Y.3    Volk, A.4    Werbizki, M.5    Dietrich, U.6    von Laer, D.7
  • 16
    • 0034467097 scopus 로고    scopus 로고
    • Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1
    • Rose NF, Roberts A, Buonocore L, Rose JK. 2000. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J. Virol. 74:10903-10910. http://dx.doi.org/10.1128/JVI.74.23.10903-10910.2000.
    • (2000) J. Virol. , vol.74 , pp. 10903-10910
    • Rose, N.F.1    Roberts, A.2    Buonocore, L.3    Rose, J.K.4
  • 18
    • 37349122809 scopus 로고    scopus 로고
    • Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice
    • Cooper D, Wright KJ, Calderon PC, Guo M, Nasar F, Johnson JE, Coleman JW, Lee M, Kotash C, Yurgelonis I, Natuk RJ, Hendry RM, Udem SA, Clarke DK. 2008. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice. J. Virol. 82:207-219. http://dx.doi.org/10.1128/JVI.01515-07.
    • (2008) J. Virol. , vol.82 , pp. 207-219
    • Cooper, D.1    Wright, K.J.2    Calderon, P.C.3    Guo, M.4    Nasar, F.5    Johnson, J.E.6    Coleman, J.W.7    Lee, M.8    Kotash, C.9    Yurgelonis, I.10    Natuk, R.J.11    Hendry, R.M.12    Udem, S.A.13    Clarke, D.K.14
  • 20
    • 9244254780 scopus 로고    scopus 로고
    • Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins
    • Miletic H, Fischer YH, Neumann H, Hans V, Stenzel W, Giroglou T, Hermann M, Deckert M, Von Laer D. 2004. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum. Gene Ther. 15:1091-1100. http://dx.doi.org/10.1089/hum.2004.15.1091.
    • (2004) Hum. Gene Ther. , vol.15 , pp. 1091-1100
    • Miletic, H.1    Fischer, Y.H.2    Neumann, H.3    Hans, V.4    Stenzel, W.5    Giroglou, T.6    Hermann, M.7    Deckert, M.8    Von Laer, D.9
  • 21
    • 0035158867 scopus 로고    scopus 로고
    • Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference
    • Beyer WR, Miletic H, Ostertag W, von Laer D. 2001. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J. Virol. 75:1061-1064. http://dx.doi.org/10.1128/JVI.75.2.1061-1064.2001.
    • (2001) J. Virol. , vol.75 , pp. 1061-1064
    • Beyer, W.R.1    Miletic, H.2    Ostertag, W.3    von Laer, D.4
  • 22
    • 79956119782 scopus 로고    scopus 로고
    • Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism
    • Muik A, Kneiske I, Werbizki M, Wilflingseder D, Giroglou T, Ebert O, Kraft A, Dietrich U, Zimmer G, Momma S, von Laer D. 2011. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J. Virol. 85:5679-5684. http://dx.doi.org/10.1128/JVI.02511-10.
    • (2011) J. Virol. , vol.85 , pp. 5679-5684
    • Muik, A.1    Kneiske, I.2    Werbizki, M.3    Wilflingseder, D.4    Giroglou, T.5    Ebert, O.6    Kraft, A.7    Dietrich, U.8    Zimmer, G.9    Momma, S.10    von Laer, D.11
  • 23
    • 0028798803 scopus 로고
    • Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus
    • Moskophidis D, Battegay M, van den Broek M, Laine E, Hoffmann-Rohrer U, Zinkernagel RM. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381-391. http://dx.doi.org/10.1099/0022-1317-76-2-381.
    • (1995) J. Gen. Virol. , vol.76 , pp. 381-391
    • Moskophidis, D.1    Battegay, M.2    van den Broek, M.3    Laine, E.4    Hoffmann-Rohrer, U.5    Zinkernagel, R.M.6
  • 24
    • 0037083612 scopus 로고    scopus 로고
    • Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses
    • Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-1532.
    • (2002) J. Immunol. , vol.168 , pp. 1528-1532
    • Foulds, K.E.1    Zenewicz, L.A.2    Shedlock, D.J.3    Jiang, J.4    Troy, A.E.5    Shen, H.6
  • 25
    • 0032804396 scopus 로고    scopus 로고
    • Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway
    • Boritz E, Gerlach J, Johnson JE, Rose JK. 1999. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73:6937-6945.
    • (1999) J. Virol. , vol.73 , pp. 6937-6945
    • Boritz, E.1    Gerlach, J.2    Johnson, J.E.3    Rose, J.K.4
  • 26
    • 0029912980 scopus 로고    scopus 로고
    • The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus
    • Schnell MJ, Buonocore L, Whitt MA, Rose JK. 1996. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70:2318-2323.
    • (1996) J. Virol. , vol.70 , pp. 2318-2323
    • Schnell, M.J.1    Buonocore, L.2    Whitt, M.A.3    Rose, J.K.4
  • 27
    • 2342637176 scopus 로고    scopus 로고
    • Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer
    • Ebert O, Shinozaki K, Kournioti C, Park MS, Garcia-Sastre A, Woo SL. 2004. Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. Cancer Res. 64:3265-3270. http://dx.doi.org/10.1158/0008-5472.CAN-03-3753.
    • (2004) Cancer Res. , vol.64 , pp. 3265-3270
    • Ebert, O.1    Shinozaki, K.2    Kournioti, C.3    Park, M.S.4    Garcia-Sastre, A.5    Woo, S.L.6
  • 28
    • 0034633740 scopus 로고    scopus 로고
    • Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production
    • Schiedner G, Hertel S, Kochanek S. 2000. Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum. Gene Ther. 11:2105-2116. http://dx.doi.org/10.1089/104303400750001417.
    • (2000) Hum. Gene Ther. , vol.11 , pp. 2105-2116
    • Schiedner, G.1    Hertel, S.2    Kochanek, S.3
  • 29
    • 0036019186 scopus 로고    scopus 로고
    • A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations
    • Kreppel F, Biermann V, Kochanek S, Schiedner G. 2002. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. Hum. Gene Ther. 13:1151-1156. http://dx.doi.org/10.1089/10430340232013 8934.
    • (2002) Hum. Gene Ther. , vol.13 , pp. 1151-1156
    • Kreppel, F.1    Biermann, V.2    Kochanek, S.3    Schiedner, G.4
  • 30
    • 84866756978 scopus 로고    scopus 로고
    • Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits
    • Mruk DD, Cheng CY. 2011. Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits. Spermatogenesis 1:121-122. http://dx.doi.org/10.4161/spmg.1.2.16606.
    • (2011) Spermatogenesis , vol.1 , pp. 121-122
    • Mruk, D.D.1    Cheng, C.Y.2
  • 31
    • 34250971354 scopus 로고
    • 50% end-point calculation
    • Kaerber G. 1931. 50% end-point calculation. Arch. Exp. Pathol. Pharmakol. 162:480-483. http://dx.doi.org/10.1007/BF01863914.
    • (1931) Arch. Exp. Pathol. Pharmakol. , vol.162 , pp. 480-483
    • Kaerber, G.1
  • 33
    • 35448959374 scopus 로고    scopus 로고
    • Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus
    • Eschli B, Zellweger RM, Wepf A, Lang KS, Quirin K, Weber J, Zinkernagel RM, Hengartner H. 2007. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J. Virol. 81: 11650-11657. http://dx.doi.org/10.1128/JVI.00955-07.
    • (2007) J. Virol. , vol.81 , pp. 11650-11657
    • Eschli, B.1    Zellweger, R.M.2    Wepf, A.3    Lang, K.S.4    Quirin, K.5    Weber, J.6    Zinkernagel, R.M.7    Hengartner, H.8
  • 35
    • 0036311547 scopus 로고    scopus 로고
    • Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology
    • Jayakar HR, Whitt MA. 2002. Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J. Virol. 76:8011-8018. http://dx.doi.org/10.1128/JVI.76.16.8011-8018.2002.
    • (2002) J. Virol. , vol.76 , pp. 8011-8018
    • Jayakar, H.R.1    Whitt, M.A.2
  • 36
    • 80555135981 scopus 로고    scopus 로고
    • Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains
    • Diallo JS, Vaha-Koskela M, Le Boeuf F, Bell J. 2012. Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Methods Mol. Biol. 797:127-140. http://dx.doi.org/10.1007/978-1-61779-340-0_10.
    • (2012) Methods Mol. Biol. , vol.797 , pp. 127-140
    • Diallo, J.S.1    Vaha-Koskela, M.2    Le Boeuf, F.3    Bell, J.4
  • 37
    • 33344479421 scopus 로고    scopus 로고
    • Antiviral antibody responses: the two extremes of a wide spectrum
    • Hangartner L, Zinkernagel RM, Hengartner H. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6:231-243. http://dx.doi.org/10.1038/nri1783.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 231-243
    • Hangartner, L.1    Zinkernagel, R.M.2    Hengartner, H.3
  • 38
    • 37549043879 scopus 로고    scopus 로고
    • Fully detargeted polyethylene glycolcoated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies
    • Wortmann A, Vohringer S, Engler T, Corjon S, Schirmbeck R, Reimann J, Kochanek S, Kreppel F. 2008. Fully detargeted polyethylene glycolcoated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies. Mol. Ther. 16:154-162. http://dx.doi.org/10.1038/sj.mt.6300306.
    • (2008) Mol. Ther. , vol.16 , pp. 154-162
    • Wortmann, A.1    Vohringer, S.2    Engler, T.3    Corjon, S.4    Schirmbeck, R.5    Reimann, J.6    Kochanek, S.7    Kreppel, F.8
  • 39
    • 56149115867 scopus 로고    scopus 로고
    • Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice
    • Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. 2008. Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice. PLoS One 3:e3548. http://dx.doi.org/10.1371/journal.pone.0003548.
    • (2008) PLoS One , vol.3
    • Croyle, M.A.1    Patel, A.2    Tran, K.N.3    Gray, M.4    Zhang, Y.5    Strong, J.E.6    Feldmann, H.7    Kobinger, G.P.8
  • 42
    • 0029829073 scopus 로고    scopus 로고
    • Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies
    • Planz O, Seiler P, Hengartner H, Zinkernagel RM. 1996. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature 382:726-729. http://dx.doi.org/10.1038/382726a0.
    • (1996) Nature , vol.382 , pp. 726-729
    • Planz, O.1    Seiler, P.2    Hengartner, H.3    Zinkernagel, R.M.4
  • 44
    • 80053371681 scopus 로고    scopus 로고
    • Viruses-from pathogens to vaccine carriers
    • Small JC, Ertl HC. 2011. Viruses-from pathogens to vaccine carriers. Curr. Opin. Virol. 1:241-245. http://dx.doi.org/10.1016/j.coviro.2011.07.009.
    • (2011) Curr. Opin. Virol. , vol.1 , pp. 241-245
    • Small, J.C.1    Ertl, H.C.2
  • 46
    • 84878826668 scopus 로고    scopus 로고
    • Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus
    • Halbherr SJ, Brostoff T, Tippenhauer M, Locher S, Berger Rentsch M, Zimmer G. 2013. Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus. PLoS One 8:e66059. http://dx.doi.org/10.1371/journal.pone.0066059.
    • (2013) PLoS One , vol.8
    • Halbherr, S.J.1    Brostoff, T.2    Tippenhauer, M.3    Locher, S.4    Berger Rentsch, M.5    Zimmer, G.6
  • 48
    • 0242500250 scopus 로고    scopus 로고
    • Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents
    • Lledo L, Gegundez MI, Saz JV, Bahamontes N, Beltran M. 2003. Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents. J. Med. Virol. 70:273-275. http://dx.doi.org/10.1002/jmv.10389.
    • (2003) J. Med. Virol. , vol.70 , pp. 273-275
    • Lledo, L.1    Gegundez, M.I.2    Saz, J.V.3    Bahamontes, N.4    Beltran, M.5
  • 52
    • 0032755419 scopus 로고    scopus 로고
    • Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion
    • Svanholm C, Bandholtz L, Lobell A, Wigzell H. 1999. Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. J. Immunol. Methods 228:121-130. http://dx.doi.org/10.1016/S0022-1759(99)00086-1.
    • (1999) J. Immunol. Methods , vol.228 , pp. 121-130
    • Svanholm, C.1    Bandholtz, L.2    Lobell, A.3    Wigzell, H.4
  • 53
    • 0031468120 scopus 로고    scopus 로고
    • Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscularDNAimmunization
    • Boyle JS, Koniaras C, Lew AM. 1997. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscularDNAimmunization. Int. Immunol. 9:1897-1906. http://dx.doi.org/10.1093/intimm/9.12.1897.
    • (1997) Int. Immunol. , vol.9 , pp. 1897-1906
    • Boyle, J.S.1    Koniaras, C.2    Lew, A.M.3
  • 54
    • 84861385675 scopus 로고    scopus 로고
    • The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate
    • Cobleigh MA, Bradfield C, Liu Y, Mehta A, Robek MD. 2012. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate. J. Virol. 86:4253-4261. http://dx.doi.org/10.1128/JVI.05991-11.
    • (2012) J. Virol. , vol.86 , pp. 4253-4261
    • Cobleigh, M.A.1    Bradfield, C.2    Liu, Y.3    Mehta, A.4    Robek, M.D.5
  • 55
    • 33745770012 scopus 로고    scopus 로고
    • Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha
    • Publicover J, Ramsburg E, Robek M, Rose JK. 2006. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. J. Virol. 80:7028-7036. http://dx.doi.org/10.1128/JVI.00478-06.
    • (2006) J. Virol. , vol.80 , pp. 7028-7036
    • Publicover, J.1    Ramsburg, E.2    Robek, M.3    Rose, J.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.